Development of highly selective therapeutics targeting NAV channel subtypes for the non-opioid treatment of pain
Ended Project Grant Awarded Last action
- Award ID
- R43DA047173
- Recipient
-
Abilita Therapeutics Inc. UEI DEYUQFS2MLT5
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $311,095
Award facts
- Assistance listing
- 93.279 Drug Use and Addiction Research Programs
- Completion date
- Originally
- Place of performance
- San Diego, CA 92121, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Original award | $311,095 |
Quick answers
Who received award R43DA047173?
R43DA047173 was awarded to Abilita Therapeutics Inc. by National Institute on Drug Abuse (National Institutes of Health) on July 1, 2018.
How much is award R43DA047173 worth?
$311,095 has been obligated on R43DA047173.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award